Penrose, Kate http://orcid.org/0000-0002-7808-7439
Srivastava, Avantika
Shen, Yanhan
Robertson, McKaylee M.
Kulkarni, Sarah G.
Allen, Kristen E.
Porter, Thomas M.
Puzniak, Laura
McLaughlin, John M.
Nash, Denis
Funding for this research was provided by:
Pfizer
Article History
Received: 25 March 2024
Accepted: 3 June 2024
First Online: 23 June 2024
Declarations
:
: Kristen E. Allen, Thomas M. Porter, Laura Puzniak and John M. McLaughlin are employees of Pfizer Inc. and hold stock and/or stock options of Pfizer Inc. Denis Nash discloses consulting fees from AbbVie and Gilead, and a research grant from Pfizer paid to his institution. Kate Penrose, Avantika Srivastava, Yanhan Shen, McKaylee M. Robertson, and Sarah G. Kulkarni report support from Pfizer through a research grant paid to their institution.
: The study protocol was approved by the Institutional Review Board at the City University of New York (CUNY IRB 2022-0407). The Institutional Review Board determined that the study met the criteria for Human Subject Research Exemption based on collection of de-identified survey data only. Consent to receive survey invitations from the Ipsos KnowledgePanel is obtained during the recruitment process. Before responding to a survey, individuals are reminded that their responses will be used for research purposes only and that they can choose not to participate or answer any question.